SOURCE: Equity News Circuit

Equity News Circuit

December 19, 2012 08:15 ET

Free Research Reports on GALE, LXRX, NUE and RGR Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Dec 19, 2012) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Galena Biopharma Inc. (NASDAQ: GALE) shares have gained over 230 percent year-to-date. The company has recently priced a public offering of 15,156,250 units at $1.60 per unit, which was a 14 percent discount to Monday's closing price.

Find out more about Galena Biopharma including full access to the free equity report at:

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares have gained over 50 percent year-to-date. The company recently announced that LX1033, a treatment for irritable bowel syndrome, has received "Fast Track" status from the FDA.

Find out more about Lexicon Pharmaceuticals including full access to the free equity report at:

Nucor Corporation (NYSE: NUE) shares have surged over 7 percent in the past week. Steel stocks have recently been boosted by data from China that has shown manufacturing in the country rose to a 14-month high in December.

Find out more about Nucor including full access to the free equity report at:

Sturm, Ruger & Company (NYSE: RGR) shares declined 7.7 percent on over 3 million shares traded Tuesday. Pressure to tighten the nation's gun laws has increased following the shooting at Sandy Hook elementary school in Connecticut.

Find out more about Sturm, Ruger & Company including full access to the free equity report at:

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information